
    
      45 sites with vertical intrabony alveolar defects will be selected. These defect sites will
      be allocated randomly into 3 groups as Group I, Group II and Group III.

        -  Group I will be treated with open flap debridement and filled with A-PRF

        -  Group II will be treated with open flap debridement and filled with Bioactive glass
           (Perioglas®)

        -  Group III will be treated with open flap debridement and filled Bioactive glass
           (Perioglas®) and A-PRF.
    
  